Boston Scientific (NYSE: BSX) opened at $8.22. So far today, the stock has hit a low of $8.08 and a high of $8.24. BSX is now trading at $8.18, up $0.03 (0.38%). The stock hit its 52-Week high...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

Medical-Devices Sector Could Face Tougher Regulatory Pathway

Republicans and Democrats will debate on TV, but little may come of it.

Can the bulls reverse a two week losing streak despite fewer number of earnings and economic releases?

The settlement resolves litigation dating to 2003 and halts a trial that was scheduled to start today in Wilmington, Delaware. Boston Scientific will pay Cordis $1 billion by the close of business today and $725 million in January 2011, the companies said in separate statements."This is a major settlement," Rick...

Boston Scientific Corporation is scheduled to report December 2009 quarter (Q4 2009) results on Wednesday, February 10, 2010. In the last four quarters ending September 2009, the company disappointed investors with below analysts’ consensus estimates.[More...]

American Medical Systems Holdings, Inc. (AMMD) recently entered into a new agreement with Tissue Genesis, Inc., an emerging leader in advanced tissue engineering and cell therapy solutions, for the research and development of adipose (fat) derived regenerative cells for use in treating pelvic health disorders. Per the agreement, American Medical has a four year option to [...]

(AMMD) American Medical Systems Holdings Earns New Agreement

The global medical devices industry is fairly large, with annual worldwide sales in excess of $200 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices, Healthcare IT, etc. We recommend companies providing life-sustaining products to investors in the medical devices [...]

(MDRX) Medical Devices Stock Review – Feburary 2010 – Industry Outlook

A patent dispute regarding Boston Scientific (BSX) cardiac stents dating back to 2003 has finally come to a close with Boston Scientific to pay Johnson & Johnson (JNJ) $1.725 billion in two tranches.  This major settlement is in addition to a separate patent settlement last September in which BSX must pay $716 million to JNJ.[More...]

American Medical Systems Holdings, Inc. (AMMD) recently entered into a new agreement with Tissue Genesis, Inc., an emerging leader in advanced tissue engineering and cell therapy solutions, for the research and development of adipose (fat) derived regenerative cells for use in treating pelvic health disorders.  Per the agreement, American Medical has a four year option to ...

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Schaeffer's Laura Houser takes a look at activity on the Street after the market close

Andrea Kramer takes a look at news on the Street ahead of the market open

Joseph Hargett takes a look back at news that drove the major market indices today.

Elizabeth Harrow takes a look at news on the Street before the market opens.